Chemoinformaics analysis of 7-(4-hydroxy-3- methoxyphenyl)-1- phenylhept-4-en-3- one
| Molecular Weight | 310.393 | nRot | 8 |
| Heavy Atom Molecular Weight | 288.217 | nRig | 14 |
| Exact Molecular Weight | 310.157 | nRing | 2 |
| Solubility: LogS | -3.567 | nHRing | 0 |
| Solubility: LogP | 3.206 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 50.4754 |
| nHD | 1 | BPOL | 24.6746 |
| QED | 0.747 |
| Synth | 2.241 |
| Natural Product Likeliness | 1.125 |
| NR-PPAR-gamma | 0.842 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.598 |
| Pgp-sub | 0.006 |
| HIA | 0.008 |
| CACO-2 | -4.699 |
| MDCK | 0.0000228 |
| BBB | 0.288 |
| PPB | 0.979872 |
| VDSS | 0.728 |
| FU | 0.0148264 |
| CYP1A2-inh | 0.965 |
| CYP1A2-sub | 0.766 |
| CYP2c19-inh | 0.963 |
| CYP2c19-sub | 0.115 |
| CYP2c9-inh | 0.896 |
| CYP2c9-sub | 0.916 |
| CYP2d6-inh | 0.848 |
| CYP2d6-sub | 0.91 |
| CYP3a4-inh | 0.822 |
| CYP3a4-sub | 0.29 |
| CL | 14.774 |
| T12 | 0.936 |
| hERG | 0.047 |
| Ames | 0.064 |
| ROA | 0.028 |
| SkinSen | 0.653 |
| Carcinogencity | 0.803 |
| EI | 0.559 |
| Respiratory | 0.092 |
| NR-Aromatase | 0.045 |
| Antiviral | No |
| Prediction | 0.687471 |